BrainsWay Ltd. (NASDAQ:BWAY – Free Report) – Equities research analysts at HC Wainwright decreased their Q1 2025 EPS estimates for BrainsWay in a research note issued on Wednesday, March 12th. HC Wainwright analyst R. Selvaraju now anticipates that the company will earn $0.03 per share for the quarter, down from their prior forecast of $0.06. HC Wainwright has a “Buy” rating and a $16.00 price objective on the stock. The consensus estimate for BrainsWay’s current full-year earnings is $0.08 per share. HC Wainwright also issued estimates for BrainsWay’s Q2 2025 earnings at $0.04 EPS, Q3 2025 earnings at $0.05 EPS, Q4 2025 earnings at $0.06 EPS, Q1 2026 earnings at $0.03 EPS, Q2 2026 earnings at $0.06 EPS, Q3 2026 earnings at $0.07 EPS, Q4 2026 earnings at $0.08 EPS and FY2026 earnings at $0.24 EPS.
BrainsWay Price Performance
NASDAQ BWAY opened at $10.21 on Friday. The stock has a market capitalization of $192.22 million, a P/E ratio of 102.11 and a beta of 1.29. The firm’s 50-day moving average is $10.26 and its two-hundred day moving average is $9.61. BrainsWay has a 12 month low of $4.61 and a 12 month high of $11.79.
Institutional Trading of BrainsWay
BrainsWay Company Profile
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases.
Featured Stories
- Five stocks we like better than BrainsWay
- P/E Ratio Calculation: How to Assess Stocks
- Rubrik Stock’s V-Bottom Reversal Signals a Major Rally Ahead
- What Do S&P 500 Stocks Tell Investors About the Market?
- How Super Micro Computer Stock Is Defying the Market Sell-Off
- 3 Grocery Stocks That Are Proving They Are Still Essential
- AppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?
Receive News & Ratings for BrainsWay Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BrainsWay and related companies with MarketBeat.com's FREE daily email newsletter.